256 results
8-K
EX-99.1
ALNY
Alnylam Pharmaceuticals Inc
2 May 24
Alnylam Pharmaceuticals Reports First Quarter 2024 Financial Results and Highlights Recent Period Activity
8:11am
. It is a double-stranded small
interfering RNA (siRNA) that targets mutant and wild-type transthyretin (TTR) messenger RNA (mRNA). Using Alnylam’s Enhanced
8-K
EX-99.1
ALNY
Alnylam Pharmaceuticals Inc
15 Feb 24
Results of Operations and Financial Condition
8:10am
amyloidosis with polyneuropathy. It is a double‑stranded small interfering RNA (siRNA) that targets mutant and wild‑type transthyretin (TTR) messenger
8-K
EX-99.1
ygjjzlwcw akl
2 Nov 23
Results of Operations and Financial Condition
8:10am
8-K
EX-99.1
r5iw9s
3 Aug 23
Alnylam Pharmaceuticals Reports Second Quarter 2023 Financial Results and Highlights Recent Period Activity
8:10am
8-K
EX-99.1
mvy1a bt1c7
4 May 23
Results of Operations and Financial Condition
8:10am
8-K
EX-99.1
qtx3b2nci 6eiwld75pu
27 Oct 22
Results of Operations and Financial Condition
8:10am
8-K
EX-99.1
873 kdf7nprx
28 Jul 22
Results of Operations and Financial Condition
8:10am
8-K
EX-99.1
5eus7a 53qwthl8
14 Jun 22
Other Events
7:30am